
associated with an increase in urinary metallothio-
nein. (See Zinc: Physiology.)
Mechanisms of Toxic Effects
0009 Once absorbed from the digestive and respiratory
tracts, or absorbed transcutaneously, mercury pro-
duces a variety of symptoms affecting the marrow,
kidneys, skin, and blood cells. In children it produces
a syndrome complex called acrodynia, or ‘pink’ dis-
ease. Acrodynia is characterized by redness of the lips
and pharynx, loss of teeth, a strawberry tongue,
swelling, redness, and desquamation of the skin,
with pink or red fingertips, palms, and soles. Redness
of the conjunctival membranes, photophobia, cer-
vical lymph node enlargement, joint pain, loss of
appetite, and vascular thromboses are also observed.
Neurological manifestations include irritability,
apathy, withdrawn behavior, proximal muscle weak-
ness and hypotonia, and diminished reflexes.
0010 Methylmercury ingestion, which has occurred
twice in Japan and in Iraq on epidemic scales, pro-
duces acute and sustained neurotoxicity. In exposed
infants, cerebral palsy-like symptoms developed, in-
cluding psychomotor retardation, microcephaly,
spastic or flaccid paralysis, ataxia, athetotic move-
ments of the hands, constriction of the visual fields,
and generalized tonic convulsions. In utero exposure
can result in distinct toxicity to the embryo, including
low birth weight, dysplasias of the cerebral and
cerebellar cortices, and an abnormal migratory
pattern of neurons. Gross findings, such as severe
mental retardation, have been reported in these
epidemics, as have more subtle findings, such as
failure to achieve developmental milestones, observed
on follow-up studies.
0011 Occupational exposure to mercury vapour has led
to acute cases of respiratory distress, renal failure
requiring dialysis, and severe oropharyngeal in-
flammation and a ‘flu-like’ syndrome. With more
prolonged exposure, proteinuria develops. The hy-
pothesized mechanism for proteinuria is stimulation
by mercury of T lymphocytes to produce an antibody
to the glomerular basement membrane. This may be
mediated in part by mercury binding to nucleoprotein
of T lymphocytes. However, it has recently been
shown that methylmercury induces T-cell apoptosis
(programmed cell death), possibly by damaging mi-
tochondria and inducing oxidative stress that acti-
vates pathways for apoptosis.
0012 Neurological symptoms in workers exposed to mer-
cury 20–35 years previously have included reduced
muscle strength and coordination, increased tremor,
decreased sensation, and increased prevalence of
abnormal reflexes. It is hypothesized that progressive
neuron loss with aging may unmask previous expos-
ure to mercury. Furthermore, mercury has been dem-
onstrated to persist in neurons for many years after
exposure has ceased. A survey of workers previously
exposed to mercury failed to reveal any impairment of
reproductive function.
0013Also of interest, although not directly observed in
humans, in vitro experiments with human platelets
have shown that mercury can produce platelet aggre-
gation and increase production of eicosanoids by
platelets. Increased platelet aggregation may contrib-
ute to the thrombus formation seen in acrodynia as
well as some of the neurological structural abnormal-
ities produced by hemorrhages in the brain secondary
to mercury exposure of animals. Despite the consider-
able exposure to mercury from dental amalgams, no
toxicity has yet been reported in humans resulting
from this exposure.
0014In animals, toxicity is of a similar nature to that
observed in humans. Rats given mercuric chloride
intravenously develop complete proximal tubular ne-
crosis. If given a high-protein diet 48 h prior to mer-
cury ingestion, they develop only partial proximal
tubular necrosis, and blood urea nitrogen and creati-
nine concentration are normal. Mechanisms for renal
injury are, at least in part, felt to be autoimmune.
Mercuric chloride administration to the brown
Norway rat not only resulted in production of anti-
glomerular basement membrane antibodies but also
induced a rise in CD4þ splenocytes, CD4þ and
CD8þ (helper and suppressor) T cells, and B lympho-
cytes in peripheral lymphoid organs. In glomeruli
there was an increase in CD8þ (suppressor) T
lymphocytes. These findings suggested that the mech-
anism for autoimmunity is T lymphocyte-dependent.
Glomerular basement membrane autoantibodies are
both immunoglobulin G (IgG) and IgM, detectable 7
days after mercury injection. The degree of protei-
nuria seen in this group of rats did not correlate
with autoantibody levels. Although glomerular hist-
ology was unremarkable in these rats, by day 18 after
injection there were vascular changes, including
endothelial cell swelling in arteries and arterioles.
Antiglomerular basement membrane IgG appeared
by day 9 after injection, peaked by day 15, and then
declined. Proximal tubular basement membrane IgG
appeared on day 9 and peritubular capillary basement
membrane IgG appeared on day 15. These antibodies
persisted for at least 30 days. Urinary metallothionein
increased after mercury administration, probably re-
flecting mercury induction of tissue metallothionein
as a means of self-protection.
0015Significant neuropathology has also been produced
by mercury in vivo, both in the fetus and in more mature
animals. In pregnant rats given an intraperitoneal
3860 MERCURY/Toxicology